At the time of writing, PDS Biotechnology Corporation [PDSB] stock is trading at $1.68, up 12.75%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PDSB shares have gain 20.86% over the last week, with a monthly amount drifted -6.93%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
PDS Biotechnology Corporation [NASDAQ: PDSB] stock has seen the most recent analyst activity on November 01, 2022, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $10. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on June 28, 2021, and set its price target to $25. On November 10, 2020, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. Alliance Global Partners started tracking the stock assigning a Buy rating and suggested a price target of $4 on May 27, 2020. Noble Capital Markets initiated its recommendation with a Outperform and recommended $5.45 as its price target on March 09, 2020. Chardan Capital Markets started tracking with a Buy rating for this stock on October 24, 2019, and assigned it a price target of $10.
For the past year, the stock price of PDS Biotechnology Corporation fluctuated between $1.30 and $6.68. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. PDS Biotechnology Corporation [NASDAQ: PDSB] shares were valued at $1.68 at the most recent close of the market. An investor can expect a potential return of 435.71% based on the average PDSB price forecast.
Analyzing the PDSB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -1.4 and Total Capital is -1.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5100 points at the first support level, and at 1.3400 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7900, and for the 2nd resistance point, it is at 1.9000.
Ratios To Look Out For
It is important to note that PDS Biotechnology Corporation [NASDAQ:PDSB] has a current ratio of 2.84. In addition, the Quick Ratio stands at 2.84 and the Cash Ratio stands at 2.71.
